Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Impaired cotranslational processing of the calcium-sensing receptor due to signal peptide missense mutations in familial hypocalciuric hypercalcemia.
[familial hypocalciuric hypercalcemia]
The
CASR
,
a
cell
surface
glycoprotein
expressed
in
parathyroid
gland
and
kidney
,
is
critical
for
maintaining
extracellular
calcium
homeostasis
.
The
inherited
disorders
,
familial
hypocalciuric
hypercalcemia
(
FHH
)
and
neonatal
severe
hyperparathyroidism
(
NSHPT
)
,
are
caused
by
inactivating
mutations
in
the
CASR
gene
.
The
CASR
has
an
N-
terminal
,
19
amino
acid
signal
peptide
that
is
predicted
to
direct
the
nascent
polypeptide
chain
,
as
it
emerges
from
the
ribosome
,
into
the
endoplasmic
reticulum
(
ER
)
.
Here
,
we
report
the
functional
characterization
of
three
CASR
mutations
identified
in
hypercalcemic
/
hyperparathyroid
patients
.
The
mutations
,
L
11
S
,
L
13
P
and
T
14
A
,
lie
within
the
signal
peptide
hydrophobic
core
.
When
transiently
transfected
into
kidney
cells
,
L
11
S
and
L
13
P
mutants
demonstrated
reduced
intracellular
and
plasma
membrane
expression
and
signaling
to
the
mitogen-activated
protein
kinase
pathway
in
response
to
extracellular
calcium
relative
to
wild-
type
CASR
and
the
T
14
A
mutant
.
All
mutant
CASR
RNAs
translated
into
protein
normally
.
In
cotranslational
processing
assays
,
which
test
the
functionality
of
the
signal
peptide
in
the
early
secretory
pathway
,
the
wild-
type
CASR
and
mutant
T
14
A
nascent
polypeptides
were
targeted
to
microsomal
vesicles
,
representing
the
ER
,
translocated
into
the
vesicular
lumen
and
underwent
core
N-
glycosylation
.
In
contrast
,
the
L
11
S
and
L
13
P
mutants
failed
to
be
inserted
in
the
microsomes
and
undergo
glycosylation
.
This
is
the
first
study
examining
the
function
of
the
CASR
signal
sequence
and
reveals
that
both
L
11
S
and
L
13
P
mutants
are
markedly
impaired
with
respect
to
cotranslational
processing
,
accounting
for
the
observed
parathyroid
dysfunction
.
Diseases
Validation
Diseases presenting
"first study"
symptom
achondroplasia
acute rheumatic fever
alexander disease
aniridia
coats disease
congenital adrenal hyperplasia
cowden syndrome
dystrophic epidermolysis bullosa
erythropoietic protoporphyria
familial hypocalciuric hypercalcemia
familial mediterranean fever
heparin-induced thrombocytopenia
hirschsprung disease
krabbe disease
locked-in syndrome
oculocutaneous albinism
primary effusion lymphoma
waldenström macroglobulinemia
wiskott-aldrich syndrome
zellweger syndrome
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom